Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma

NCT00085696

Conditions
B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Emory University Cancer Institute, Winship Cancer Institute Atlanta, Georgia, United States
  • Georgia Cancer Specialists Marietta, Georgia, United States
View all 13 locations
View Trial Details
Completed

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

NCT00063713

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Alta Bates Medical Center Berkeley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Loma Linda Cancer Research Institute Loma Linda, California, United States
View all 35 locations
View Trial Details
Completed

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00090090

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +18 more
Locations
  • Alta Bates Cancer Center Berkeley, California, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Tower Hematology Oncology Medical Group Los Angeles, California, United States
View Trial Details

Related conditions